IκB-Kinase-εμ (IKKεμ/IKKi/IκBKεμ) expression and localization in prostate cancer tissues

Prostate

Volumn 71, Issue 10, 2011, Pages 1131-1138

  Péant, Benjamin ^a   Forest, Valérie ^a   Trudeau, Vincent ^c   Latour, Mathieu ^a   Mes Masson, Anne Marie ^a,c   Saad, Fred ^a,b,c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

cancer progression; IKK ; immunohistochemistry; prostate cancer; TMA

Indexed keywords

I KAPPA B KINASE EPSILON; PARAFFIN;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER TISSUE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; TISSUE MICROARRAY;

AGED; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CELL LINE, TUMOR; HUMANS; I-KAPPA B KINASE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROSTATE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 79955815187     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21329     Document Type: Article

References (26)

1. Gittes RF,. Carcinoma of the prostate. N Engl J Med 1991; 324 (4): 236-245.
2. Landis SH, Murray T, Bolden S, Wingo PA,. Cancer statistics, 1999. CA Cancer J Clin 1999; 49 (1): 8-31, 31. (Pubitemid 29094959)
3. Abate-Shen C, Shen MM,. Molecular genetics of prostate cancer. Genes Dev 2000; 14 (19): 2410-2434.
4. Nelson CC, Hoffart D, Gleave ME, Rennie PS,. Application of gene microarrays in the study of prostate cancer. Methods Mol Med 2003; 81: 299-320.
5. Tricoli JV, Schoenfeldt M, Conley BA,. Detection of prostate cancer and predicting progression: Current and future diagnostic markers. Clin Cancer Res 2004; 10 (12 Pt 1): 3943-3953. (Pubitemid 38812467)
6. Fradet V, Lessard L, Begin LR, Karakiewicz P, Masson AM, Saad F,. Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer. Clin Cancer Res 2004; 10 (24): 8460-8464. (Pubitemid 40053410)
7. Lessard L, Mes-Masson AM, Lamarre L, Wall L, Lattouf JB, Saad F,. NF-kappa B nuclear localization and its prognostic significance in prostate cancer. BJU Int 2003; 91 (4): 417-420. (Pubitemid 36359653)
8. Barnes PJ, Karin M,. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336 (15): 1066-1071. (Pubitemid 27163860)
9. Huang F, Horikoshi S, Kurusu A, Shibata T, Suzuki S, Funabiki K, Shirato I, Tomino Y,. Urinary levels of interleukin-8 (IL-8) and disease activity in patients with IgA nephropathy. J Clin Lab Anal 2001; 15 (1): 30-34.
10. Zerbini LF, Wang Y, Cho JY, Libermann TA,., Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Cancer Res 2003; 63 (9): 2206-2215. (Pubitemid 36538628)
11. Culig Z, Steiner H, Bartsch G, Hobisch A,. Interleukin-6 regulation of prostate cancer cell growth. J Cell Biochem 2005; 95 (3): 497-505. (Pubitemid 41420180)
12. Giri D, Ozen M, Ittmann M,. Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol 2001; 159 (6): 2159-2165. (Pubitemid 33104270)
13. Uehara H, Troncoso P, Johnston D, Bucana CD, Dinney C, Dong Z, Fidler IJ, Pettaway CA,. Expression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stage. Prostate 2005; 64 (1): 40-49. (Pubitemid 40734737)
14. Aupperle KR, Yamanishi Y, Bennett BL, Mercurio F, Boyle DL, Firestein GS,. Expression and regulation of inducible IkappaB kinase (IKK-i) in human fibroblast-like synoviocytes. Cell Immunol 2001; 214 (1): 54-59. (Pubitemid 34280756)
15. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T,. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 2003; 4 (5): 491-496. (Pubitemid 36592443)
16. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J,. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003; 300 (5622): 1148-1151. (Pubitemid 36583100)
17. Peant B, Diallo JS, Lessard L, Delvoye N, Le Page C, Saad F, Mes-Masson AM,. Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer. Mol Cancer Res 2007; 5 (1): 87-94.
18. Peant B, Diallo JS, Dufour F, Le Page C, Delvoye N, Saad F, Mes-Masson AM,. Over-expression of IkappaB-kinase-epsilon (IKKepsilon/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell lines. Prostate 2009; 69 (7): 706-718.
19. Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, Dunn IF, Sjostrom SK, Garraway LA, Weremowicz S, Richardson AL, Greulich H, Stewart CJ, Mulvey LA, Shen RR, Ambrogio L, Hirozane-Kishikawa T, Hill DE, Vidal M, Meyerson M, Grenier JK, Hinkle G, Root DE, Roberts TM, Lander ES, Polyak K, Hahn WC,. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007; 129 (6): 1065-1079. (Pubitemid 46891036)
20. Guo JP, Shu SK, He L, Lee YC, Kruk PA, Grenman S, Nicosia SV, Mor G, Schell MJ, Coppola D, Cheng JQ,. Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer. Am J Pathol 2009; 175 (1): 324-333.
21. Seo SI, Song SY, Kang MR, Kim MS, Oh JE, Kim YR, Lee JY, Yoo NJ, Lee SH,. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers. Acta Pathol Microbiol Immunol Scand 2009; 117 (8): 623-628.
22. Le Page C, Koumakpayi IH, Alam-Fahmy M, Mes-Masson AM, Saad F,. Expression and localisation of Akt-1, Akt-2 and Akt-3 correlate with clinical outcome of prostate cancer patients. Br J Cancer 2006; 94 (12): 1906-1912. (Pubitemid 43882583)
23. Koumakpayi IH, Le Page C, Mes-Masson AM, Saad F,. Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer. Br J Cancer 2010; 102 (7): 1163-1173.
24. Domingo-Domenech J, Mellado B, Ferrer B, Truan D, Codony-Servat J, Sauleda S, Alcover J, Campo E, Gascon P, Rovira A, Ross JS, Fernandez PL, Albanell J,. Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer 2005; 93 (11): 1285-1294. (Pubitemid 41679415)
25. Ross JS, Kallakury BV, Sheehan CE, Fisher HA, Kaufman RP Jr, Kaur P, Gray K, Stringer B,. Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: Correlation of nuclear factor-kappa B immunoreactivity with disease recurrence. Clin Cancer Res 2004; 10 (7): 2466-2472. (Pubitemid 38445708)
26. Eddy SF, Guo S, Demicco EG, Romieu-Mourez R, Landesman-Bollag E, Seldin DC, Sonenshein GE,. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells. Cancer Res 2005; 65 (24): 11375-11383. (Pubitemid 41823949)